Abstract:Objectives Several epidemiological and experimental evidences indicate that oestrogen is intimately involved in the pathogenesis of atherosclerosis. The anti-proliferatory, pro-apoptotic, anti-migratory, anti-oxidative, and anti-inflammatory effects of oestrogen on vascular smooth muscle cells (VSMCs) have been demonstrated in vitro . However the role of oestrogen and its underlying mechanism in lipid accumulation and reverse cholesterol transport in VSMCs are poorly understood. The aim of the study was to investigated whether 17β-estradiol (E2) attenuates lipid accumulation in VSMCs via an increased cholesterol efflux as well as to determine the involved molecular mechanisms. Methods Mouse VSMCs were pretreated with indicated concentrations of E2 (10-9-10-7M) for 2h and then stimulated with oxLDL (50 μg/ml) for 72h. The intracellular lipid droplets were stained by oil red O staining and hematoxylin was used as a counterstain. Cellular free cholesterol and cholesteryl ester were quantified by an enzymatic method. The effect of E2 on cholesterol efflux was investigated using NBD-labelled cholesterol efflux. Real-time PCR and western blotting were used to detect the effect of E2 on ATP-binding cassette transporters (ABCA1), ABCG1 and liver X receptor (LXRα). Western blotting and NBD-labled cholesterol efflux were also used to examine the effects of oestrogen receptor (ER) and LXRα on E2-induced ABCA1 and ABCG1 expression and cholesterol efflux in VSMCs. Results E2 treatment dose-dependently reduced lipid droplets and celluar cholesteryl ester accumulation in VSMCs. E2 markedly enhanced apoA-1- and HDL-mediated cholesterol efflux from VSMCs in a dose-dependent manner, which was associated with an increase in ABCA1 and ABCG1 mRNA and protein expression. Nonselective ER inhibitor ICI-182,780 abolished the upregulation of ABCA1 and ABCG1 expression by E2. Remarkably, ERβ agonist DPN dose dependently upregulated ABCA1 and ABCG1 protein expression, whereas ERα agonist PPT had no effect, indicating upregulation of ABCA1 and ABCG1 by E2 is selectively mediated by ERβ. Both E2 and DPN promoted LXRα mRNA and protein expression in VMSCs. Moreover, inhibition of LXRα with a pharmacological inhibitor GGPP or siRNA suppressed the stimulatory effects of E2 on ABCA1 and ABCG1 expression and cholesterol efflux. Conclusions ERβ- and LXRα-dependent upregulation of ABCA1 and ABCG1 might mediate the atheroprotective effect of E2, which ameliorated the oxLDL-mediated lipid accumulation in VSMCs-derived foam cell formation.

Down-regulation of ETA receptor of vascular smooth muscle cells by 17 beta-estradiol]

Down-regulation of ETA receptor of vascular smooth muscle cells by 17β-estradiol

Role of Caveolin-1 on Down-Regulation of LPS-induced Monocyte Chemotactic Protein 1 by 17Β-Estradiol in Vascular Smooth Muscle Cells

17β-Estradiol inhibits oleic acid-induced rat VSMC Proliferation and migration by restoring PGC-1α expression

17SS-Estradiol Antagonizes the Down-Regulation of ERα/NOS-3 Signaling in Vascular Endothelial Dysfunction of Female Diabetic Rats.

[Effect of ERK on 17Beta-Estradiol-induced Inhibition of VSMC Proliferation in Rats after Vascular Injury].

17β-Estradiol inhibits proliferation and migration of human vascular smooth muscle cells: similar effects in cells from postmenopausal females and in males

17beta-estradiol inhibits oleic acid-induced rat VSMC proliferation and migration by restoring PGC-1alpha expression.

Effect of estrogen on vascular endothelial growth factor expression in rat osteoblasts

17Β-Estradiol Promotes Angiogenesis of Rat Cardiac Microvascular Endothelial Cells in Vitro.

E0105 in Vitro Blockade of Oestrogen Receptor Promotes the Proliferation of Vascular Smooth Muscle Cells

GW24-e2301 17β-estradiol reduces lipid accumulation in vascular smooth muscle cells through liver X receptor α pathway

Effects of 17-β-Estradiol on Proliferation of Vascular Smooth Muscle Cells Induced by Thrombin and c-fos,Bcl-2 Expression

Effect of endothelin-1 on the proliferation and phenotypic transformation of vascular smooth muscle cells in rat

[Inhibitory Effects of 17Beta-Estradiol on Spontaneous and Activated Contraction of Rat Uterus Smooth Muscle].

Estrogen accelerates G1 to S phase transition and induces a G2/M phase-predominant apoptosis in synthetic vascular smooth muscle cells.

17 Beta-Estradiol Promotes Cholesterol Efflux From Vascular Smooth Muscle Cells Through A Liver X Receptor Alpha-Dependent Pathway

[Effects of 17 Beta-Estradiol on the Gene Expression of Shear Stressed Endothelial Cells].

[Effect of Endothelin-1 Stimulation on Peroxisome Proliferator-Activated Receptor-Gamma Expression in Vascular Smooth Muscle Cells].

Rapid Estrogen Receptor Signaling Mediates Estrogen-Induced Inhibition of Vascular Smooth Muscle Cell Proliferation

Intervention effect of puerarin and biochanin A on 17β-estradiol-induced endometrial exudation